Aloe Blacc’s fame means nothing in biotech (and that’s the point)

When the singer-songwriter was nominated Hello black He contracted the coronavirus despite being vaccinated and boosted, and tried to fund research for a better solution. What did he discover quickly? You can’t just write a check in biotech. Regulators require a plan for commercialization, and philanthropy does not communicate science through clinical trials or give you a license to university intellectual property. Now he is bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that kills 90% of his patients, and is deliberately waiting to be rolled out of his network until peer-reviewed research can make his case.

Watch Aloe Blacc join TechCrunch’s Rebecca Bellan justice A podcast to talk about what happens when a creator decides to build instead of just invest, how Aloe is watching AI reshape the biotech and music industries in real time, and his thoughts on who actually wins.

Subscribe to shares on YouTube, Apple Podcast, Overcast, Spotify And all the actors. You can also follow stocks on X and TopicsatEquityPod.